,
!
1. K/DOQI :
A)
B)
C)
D) 89 /
E) 100 /
2. , :
A) -
B)
C)
D)
E)
3. ?
A)
B)
C)
D)
E)
4. K/DOQI :
A) MDRD
B)
C) -
D) MDRD
E) -
5. 2- :
A) 90-120 /
B) 60-89 /
C) < 60 /
D) < 30 /
E) 15-29 /
6. :
A)
B) 2
C) 2
D)
E)
7. ?
A)
B)
C)
D)
E) 3
8. ?
A)
B)
C)
D)
E)
9. 14 . : 160/95..., : Hb 100/, 26/, 0,5 /; : 0,33 /, 5-10 /, 10-20 /; 25/. : , C. ?
A) ,
B) 2
C) 3
D) 4
E) ,
10. 12 , 170/100... : Hb 115/, 26/; 200 /, 50/, : 0,33 /, 10-15 /, 10-20 /. : C. ?
|
|
|
A) ,
B) 2
C) 3
D) 4
E) ,
11. ?
A)
B)
C)
D)
E)
12. :
A)
B)
C)
D)
E)
13. :
A) -II
B)
C)
D) , II
E) , II
14. II:
A) -II
B)
C)
D) , II
E) , II
15. II:
A)
B)
C)
D)
E)
16. - :
A)
B)
C)
D)
E)
17. :
A)
B)
C) -2-
D)
E)
18. 13 , 180/100 . : 0,3 /, 110/. : , , . ?
A)
B)
C)
D)
E)
19. 13 , 180/100 . : 0,3 /, 110/. : , , . , 150/90... ?
A) +
B) +
C) +
D) +
E) +
20. 13 , 180/100 . : 0,3 /, 110/. : , , . , 150/90... :
A) 120/80 ...
B) 140/90 ...
C) 130/80 ...
D)
|
|
|
E) 135/95...
21. C?
A)
B)
C)
D)
E) p
22. 5 ?
A)
B)
C)
D)
E)
23. , :
A)
B)
C)
D)
E)
24. :
A) -
B)
C)
D) -
E) --
25. 10 . :
A)
B)
C)
D)
E)
26. :
A)
B)
C)
D)
E)
27. :
A)
B)
C)
D)
E)
28. 14 , 0,165 /. 59 /. ?
A) IgA
B)
C)
D)
E)
29. 16 , . -78 /, 0,32 /. ?
A)
B) Β-
C)
D)
E)
30. :
A)
B)
C)
D)
E)
| E | D | E | |||||||
| A | A | ||||||||
| E | D | A | |||||||
| B | C | ||||||||
| B | E | D | D | ||||||
| D | A |
1 .. . . , 2005. 352 .
2 .., .. //. 2009. 1. . 1-6.
3 .., .. . .: , 2007. 537 .
4 .., .., .., .. //. 2005. .9, 4. . 7-12.
5 .., .., .., . // . 2009. - 1-2. . 59-61.
6 .., .., .. //. . 2007. - 6. . 75-8.
7 K/DOKI clinical practice guidelines for chronic kidney diseases: evaluation, classification and stratification//Am J Kidney Dis. 2002. Vol. 39, 1. P. 17-31.
|
|
|
8 K/DOQI, National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. // Am. J. Kidney Dis. 2005. Vol. 46, N 4, Suppl. 1. P. S1S121.
9 K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease//Am J Kidney Dis. 2006. Vol 47, l3. . l-146.
10 Kidney International. Chronic Kidney Disease as a Global Public Health Problem: Approaches and Initiatives A Position Statement from Kidney Disease Improving Global Outcomes//International society of Nephrology. 2007. Vol. 72. P. 247-259.
11 KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target//Am J Kidney Dis. 2007. Vol. 50, 3. . 471-530.
12 Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference//Clin J Am Soc Nephrol. 2008. Vol. 3, 2. . 471-80.
13 KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary//Am J Kidney Dis. 2009. Vol. 53, 3. . 11-104.
14 S, Drueke T, Cunningham J, et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)//Kidney Int. 2005. Vol. 67. . 2089-100.
